Taysha Gene Therapies (TSHA)
(Delayed Data from NSDQ)
$2.18 USD
+0.04 (1.87%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $2.18 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Price, Consensus and EPS Surprise
TSHA 2.18 +0.04(1.87%)
Will TSHA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TSHA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TSHA
Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Lags Revenue Estimates
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
TSHA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates
Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates
Other News for TSHA
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
What You Missed On Wall Street This Morning
Biggest stock movers today: VSTO, WHR, FDX, TSHA and more
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Taysha Gene Therapies announces pricing of public offering of common stock and pre-funded warrants